Villarin Joseph M, Kellendonk Christoph
Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, 10032, USA.
Department of Psychiatry, Columbia University, New York, NY, 10032, USA.
Mol Psychiatry. 2025 May 22. doi: 10.1038/s41380-025-03060-7.
In applying model organisms to study the neurobiology of mental disorders, rodents offer unique potential for probing, with high spatiotemporal resolution, the neural and molecular mechanisms underlying behavior in a mammalian system. Furthermore, investigators can wield exceptional power to manipulate genes, molecules, and circuits in mice to pin down causal relationships. While these advantages have allowed us to understand much more deeply than ever before the brain mechanisms regulating complex behaviors, the impact of rodent models on developing therapeutic strategies for psychiatric disorders has remained thus far limited. Herein, we will discuss the opportunities and limits of using mouse models in the context of schizophrenia, a complex psychiatric disorder with strong genetic basis that poses various unmet clinical needs calling out for basic science research. We review approaches for employing behavioral, genetic, and circuit-based methods in rodents to inform schizophrenia symptomatology, pathophysiology, and, ultimately, treatment.
在应用模式生物来研究精神障碍的神经生物学时,啮齿动物具有独特的潜力,能够以高时空分辨率探究哺乳动物系统中行为背后的神经和分子机制。此外,研究人员能够在小鼠中对基因、分子和神经回路进行极为有效的操控,以确定因果关系。尽管这些优势使我们比以往任何时候都更深入地理解了调节复杂行为的大脑机制,但迄今为止,啮齿动物模型对精神疾病治疗策略开发的影响仍然有限。在此,我们将在精神分裂症的背景下讨论使用小鼠模型的机遇和局限,精神分裂症是一种具有强大遗传基础的复杂精神疾病,存在各种未满足的临床需求,亟需基础科学研究。我们回顾了在啮齿动物中采用基于行为、基因和神经回路的方法来了解精神分裂症的症状学、病理生理学以及最终治疗方法的途径。